Literature DB >> 11819029

Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.

Hongxia Zhou1, Angelika Meyer, Klaus Starke, Jesus Gomeza, Jürgen Wess, Anne-Ulrike Trendelenburg.   

Abstract

Release-inhibiting muscarinic autoreceptors were studied in heart atria and the urinary bladder of NMRI mice, M(2)-receptor-deficient mice, M(4)-receptor-deficient mice, and wildtype mice sharing the genetic background of the knockout animals. Segments of the tissues were preincubated with (3)H-choline and then superfused and stimulated electrically. In atrial segments taken from adult mice and stimulated with 120 pulses at 1 Hz, the muscarinic receptor agonist oxotremorine-M reduced the evoked overflow of tritium. Its concentration-response curves in atria from NMRI, M(2)-wildtype, M(4)-wildtype and M(2)-knockout mice were similar, with maximal inhibition by about 75%. In atria from M(4)-knockout mice, the maximal inhibitory effect of oxotremorine-M was reduced to 57%. The concentration-response curves of oxotremorine-M were shifted to the right by ipratropium, methoctramine and pirenzepine. Methoctramine and pirenzepine were approximately equipotent antagonists in all strains except in M(4)-knockout atria in which methoctramine was more potent than pirenzepine. When atria from adult NMRI mice were stimulated by 360 pulses at 3 Hz, ipratropium increased the evoked overflow of tritium both in the absence and in the presence of physostigmine (0.1 microM). In atria taken from 1-day-old NMRI mice, oxotremorine-M failed to reduce the evoked overflow of tritium. In bladder segments taken from adult mice, superfused with medium containing oxotremorine-M (1 microM), and stimulated by 360 pulses at 3 Hz, ipratropium increased the evoked overflow of tritium. Its concentration-response curves in preparations from NMRI, M(2)-wildtype, M(4)-wildtype and M(2)-knockout mice were similar. There was one exception: ipratropium failed to cause an increase in bladder pieces from M(4)-knockout mice. Methoctramine and pirenzepine also increased the evoked overflow of tritium in all strains except the M(4)-knockout. The two antagonists were approximately equipotent in NMRI, M(4)-wildtype and M(2)-knockout preparations but methoctramine was less potent than pirenzepine in M(2)-wildtype preparations. When bladder pieces from adult NMRI mice were superfused with oxotremorine-M-free medium and stimulated by 360 pulses at 3 Hz, ipratropium increased the evoked overflow of tritium in the presence of physostigmine (0.1 microM) but not in its absence. In bladder segments taken from 1-day-old NMRI mice and superfused with medium containing oxotremorine-M (1 microM), ipratropium increased the evoked overflow of tritium in the same way as in adult tissue. It is concluded that NMRI mice and the two wildtype strains are similar in their muscarinic autoreceptors. In atria, the autoreceptors are heterogeneous. Some are M(4). The non-M(4)-autoreceptors probably are M(2). In the bladder, the autoreceptors are exclusively M(4). In both tissues, the autoreceptors are activated by previously released acetylcholine under appropriate conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819029     DOI: 10.1007/s00210-001-0517-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  Muscarinic receptors in isolated urinary bladder smooth muscle from different mouse strains.

Authors:  A Choppin
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

Review 2.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice.

Authors:  Anne-Ulrike Trendelenburg; Angelika Meyer; Jürgen Wess; Klaus Starke
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

4.  Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback.

Authors:  Klaus Deckmann; Amir Rafiq; Christian Erdmann; Christian Illig; Melanie Durschnabel; Jürgen Wess; Wolfgang Weidner; Thomas Bschleipfer; Wolfgang Kummer
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

5.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

6.  Activation of muscarinic receptors in rat bladder sensory pathways alters reflex bladder activity.

Authors:  F Aura Kullmann; Debra E Artim; Lori A Birder; William C de Groat
Journal:  J Neurosci       Date:  2008-02-20       Impact factor: 6.167

7.  Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice.

Authors:  Yoshihiko Ito; Luvsandorj Oyunzul; Masanao Seki; Tomomi Fujino Oki; Minoru Matsui; Shizuo Yamada
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

Review 8.  Muscarinic receptors in the bladder: from basic research to therapeutics.

Authors:  Sharath S Hegde
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

9.  Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release: a study with M2- and M4-receptor-deficient mice.

Authors:  Anne-Ulrike Trendelenburg; Jesus Gomeza; Werner Klebroff; Hongxia Zhou; Jürgen Wess
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.